Skip to main content
Clinical Trials/NL-OMON40674
NL-OMON40674CompletedNot Applicable

Exogenous creatine kinase and platelet aggregation - Exogenous CK and platelets

Academisch Medisch Centrum0 sites6 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
6

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Women between 18 and 50 years old, with no known disease or drug use.

Exclusion Criteria

  • Current disease, personal and family history of bleeding or coagulation abnormalities, intensive exercise in the three days prior to participation, drug use, use of acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs) in the two weeks prior to participation, usage of the supplement creatine (or a creatine analogue), current smoking.

Investigators

Similar Trials